NAMRU-6 Virology and Emerging Infections Department (VEID) is seeking to purchase laboratory reagents and consumables to be used for molecular diagnosis of viruses associated with ongoing protocols studying respiratory and arboviral diseases across multiple study sites and polymerase chain reaction (PCR) platforms. Specifically, the requirement involves PCR enzymes for reverse transcription, and real-time platforms. Standard operating procedures for the use of these reagents have been developed for each pathogen and validated to ensure requirements for scientific rigor are met in regard to precision and accuracy. Standardization and validation of experiments have been performed using reagents such as Taqman Fast Virus 1-Step, SuperScript III 1-Step qRT-PCR, Fast 7500 Spectral Calibration Kit, and others.
The use of the above reagents has proven compatible with NAMRU-6 diagnostic equipment and procedures and altering brand or vendor represents a loss in result comparability, supervisor and technician time to develop and validate new procedures and results, and potential logistics barriers given our overseas location and supply support system. The PCR assays have been developed independently for each SOP and involve much time and effort by laboratory technicians, and supervisors for final approval. Reagents used must remain the same as the ones indicated in the SOPs, otherwise the design and validation of these processes would have to be re-initiated, which would delay all processing and the timely diagnosis of public health relevant pathogens.
If capable sources are not identified through this notice, then NAMRU 6 intends to award a sole source contract under the authority of 13.106-1(b)(i) to Life Technologies Corporation for the requirements of these products.
This pre-solicitation is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.
Capability statements are due by 12:00 PM Local Time, 01 Aug 2018. Capability statements shall be submitted by e-mail only as a Microsoft Word or Adobe PDF attachment to the following address: [email protected]. Please use subject line "N44852VEID180687"

 

 

Bid Protests Not Available